$767 Million is the total value of SNS Financial Group, LLC's 285 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FV | FIRST TR EXCHANGE-TRADED FDdorsey wrt 5 etf | $1,537,000 | -13.1% | 37,108 | 0.0% | 0.20% | +2.0% | |
| OTTR | OTTER TAIL CORP | $495,000 | +7.4% | 7,371 | 0.0% | 0.06% | +25.5% | |
| DNOV | FIRST TR EXCHNG TRADED FD VIcboe eqt dep nov | $410,000 | -6.6% | 12,658 | 0.0% | 0.05% | +8.2% | |
| MGPI | MGP INGREDIENTS INC NEW | $350,000 | +16.7% | 3,500 | 0.0% | 0.05% | +39.4% | |
| PTLC | PACER FDS TRtrendp us lar cp | $313,000 | -3.4% | 8,344 | 0.0% | 0.04% | +13.9% | |
| IWS | ISHARES TRrus mdcp val etf | $309,000 | -15.1% | 3,041 | 0.0% | 0.04% | 0.0% | |
| IYH | ISHARES TRus hlthcare etf | $231,000 | -6.9% | 860 | 0.0% | 0.03% | +7.1% | |
| FNDB | SCHWAB STRATEGIC TRschwab fdt us bm | $229,000 | -13.3% | 4,566 | 0.0% | 0.03% | +3.4% | |
| JAGG | J P MORGAN EXCHANGE TRADED Fus aggregate etf | $209,000 | -5.0% | 4,356 | 0.0% | 0.03% | +12.5% | |
| VHT | VANGUARD WORLD FDShealth car etf | $208,000 | -7.6% | 884 | 0.0% | 0.03% | +8.0% | |
| DCI | DONALDSON INC | $210,000 | -7.5% | 4,368 | 0.0% | 0.03% | +8.0% | |
| AVXL | ANAVEX LIFE SCIENCES CORP | $200,000 | -18.7% | 20,000 | 0.0% | 0.03% | -3.7% | |
| ENZ | ENZO BIOCHEM INC | $129,000 | -28.7% | 62,500 | 0.0% | 0.02% | -15.0% | |
| CELC | CELCUITY INC | $124,000 | -2.4% | 13,593 | 0.0% | 0.02% | +14.3% | |
| ACTG | ACACIA RESH CORP | $111,000 | +12.1% | 22,000 | 0.0% | 0.01% | +27.3% | |
| CLSK | CLEANSPARK INC | $53,000 | -68.6% | 13,640 | 0.0% | 0.01% | -63.2% | |
| UP | WHEELS UP EXPERIENCE INC | $36,000 | -36.8% | 18,300 | 0.0% | 0.01% | -16.7% | |
| SOLO | ELECTRAMECCANICA VEHS CORP | $27,000 | -37.2% | 20,000 | 0.0% | 0.00% | -20.0% | |
| AMRN | AMARIN CORP PLCspons adr new | $20,000 | -54.5% | 13,500 | 0.0% | 0.00% | -40.0% | |
| AQB | AQUABOUNTY TECHNOLOGIES INC | $17,000 | -10.5% | 10,000 | 0.0% | 0.00% | 0.0% | |
| CLVS | CLOVIS ONCOLOGY INC | $18,000 | -10.0% | 10,000 | 0.0% | 0.00% | 0.0% | |
| EVGN | EVOGENE LTD | $8,000 | -38.5% | 10,000 | 0.0% | 0.00% | 0.0% | |
| AMPE | AMPIO PHARMACEUTICALS INC | $7,000 | -63.2% | 40,000 | 0.0% | 0.00% | -50.0% | |
| AIM | AIM IMMUNOTECH INC | $8,000 | -27.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Anchor #1
- Dimensional Fund Advisors #2
- Parametric #3
- Other #4
- Vector WM #5
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-07-22
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR TR S&P 500 ETF TR | 46 | Q2 2024 | 14.9% |
| ISHARES TR | 46 | Q2 2024 | 10.8% |
| ISHARES TR | 46 | Q2 2024 | 6.2% |
| APPLE INC | 46 | Q2 2024 | 4.2% |
| SPDR SERIES TRUST | 46 | Q2 2024 | 7.4% |
| VANGUARD INTLS EQUITY INDEX F | 46 | Q2 2024 | 5.4% |
| ISHARES TR | 46 | Q2 2024 | 3.0% |
| ISHARES TR | 46 | Q2 2024 | 3.1% |
| VANGUARD INDEX FDS | 46 | Q2 2024 | 0.9% |
| JOHNSON & JOHNSON | 46 | Q2 2024 | 1.3% |
View SNS Financial Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AdvisorShares Trust | February 04, 2014 | 23,451 | 6.2% |
View SNS Financial Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-20 |
| 13F-HR | 2024-07-25 |
| 13F-HR | 2024-04-24 |
| 13F-HR | 2024-01-22 |
| 13F-HR | 2023-10-19 |
| 13F-HR | 2023-07-17 |
| 13F-HR | 2023-04-28 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-10-12 |
| 13F-HR | 2022-07-22 |
View SNS Financial Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.